AIHealthcare

Eko Health is a privately held digital health and medical-device company that combines digital stethoscopes, ECG and auscultation data, patient and provider software, and FDA-cleared artificial intelligence to support earlier detection and monitoring of cardiovascular and pulmonary disease. Its SENSORA platform and related algorithms are designed to help clinicians identify conditions including structural heart murmurs, atrial fibrillation, and low ejection fraction during routine or remote examinations. The company sells to healthcare professionals and health systems and has expanded internationally, including a UK launch in 2025. Public company materials describe the platform as being used by more than 500,000 healthcare professionals worldwide at the time of its June 2024 financing announcement; later public claims report more than 600,000 users, but exact current deployment figures are not independently verified here.